Pmv Pharmaceuticals Inc's Customers Performance

Name: Pmv Pharmaceuticals Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

PMVP

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


PMVP's Source of Revenues		• List of PMVP Customers

for the same period Pmv Pharmaceuticals Inc

• List of PMVP Customers

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Pmv Pharmaceuticals Inc's Comment on Sales, Marketing and Customers

News about Pmv Pharmaceuticals Inc Contracts

Rezatapopt Pioneering Precision Oncology in TP53 Y220C Mutated Solid Tumors

The role of TP53 mutations in cancer has long been regarded as a critical factor in tumorigenesis and therapeutic resistance. With the advent of targeted therapies, the need for innovative approaches to treat malignancies harboring specific mutations has grown considerably. PMV Pharmaceuticals has taken substantial steps towards this goal with the development of rezatapopt, a small molecule targeting mutant p53. This article delves into the recently updated data from the ongoing Phase 2 PYNNACLE trial, highlighting the efficacy and safety of rezatapopt in treating advanced solid tumors exhibiting a TP53 Y220C mutation. The tumor suppressor gene TP53 plays a pivotal role in maintaining genomic integrity and ...

Advancing Precision Oncology PMV Pharmaceuticals Reports Promising Financial Results and Progress Update on PYNNACLE ...

PMV Pharmaceuticals, Inc. has provided an update on its financial performance and ongoing clinical endeavors regarding its lead oncology candidates. This article summarizes the second-quarter financial results for 2024 and outlines the progress in the PYNNACLE clinical trial focused on novel therapies targeting the p53 protein, which is frequently mutated in a variety of cancers. PMV Pharmaceuticals, based in Princeton, New Jersey, is at the forefront of precision oncology, specifically aimed at discovering and developing therapies that act on the widely recognized tumor suppressor protein, p53. This article reviews the company’s financial results for the second quarter of 2024 and highlights the int...

Augmenting Precision Oncology: Foundation Medicine and PMV Pharma Collaborate to D...

The biopharmaceutical industry has witnessed a groundbreaking collaboration between Foundation Medicine, Inc., a leading molecular information company, and PMV Pharmaceuticals, Inc., an innovative precision oncology company. This strategic partnership aims to develop a companion diagnostic for PMV Pharma s groundbreaking therapy, rezatapopt, which targets patients with locally advanced or metastatic solid tumors bearing the TP53 Y220C mutation.Foundation Medicine s state-of-the-art tissue-based comprehensive genomic profiling test, FoundationOneCDx, will be leveraged as the companion diagnostic for rezatapopt. The test has gained significant recognition for its ability to assess various genetic alterations s...

PMVP's Stock Performance relative to it's Customers

PMVP's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Pmv Pharmaceuticals Inc	73.14	0.00	-75.22	54
SUBTOTAL	0.00	0.00	0.00	-

Sources: Pmv Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Pmv Pharmaceuticals Inc’s corporate clients.
For your research, we’ve provided 9 tables on Pmv Pharmaceuticals Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.